by Truveta Staff | Sep 28, 2023 | Technology
It’s only September, but COVID-19 and respiratory syncytial virus (RSV) cases are already rising. The latest Truveta Research monitoring report shows that for people over 65, COVID continues to be the most prevalent respiratory virus associated with hospitalizations....
by Truveta Research | Aug 31, 2023 | Research, Research Insights
Compared to July, Truveta Data shows a 70.1% increase in the rate of COVID-19 positive tests and a 74.1% increase in the percentage of hospitalizations associated with COVID. Compared to 7 days prior, we see an 11.2% increase in the rate of COVID positive tests and an...
by Truveta Staff | Aug 22, 2023 | Technology
RSV season, which typically starts in fall and peaks in winter, could look very different this year. With newly approved vaccines for older adults and pregnant women and an immunization for infants poised to roll out, public health experts are optimistic about...
by Truveta Staff | Jul 28, 2023 | Technology
Scientists from the Institute for Systems Biology (ISB) have published new research in the JMIR Public Health and Surveillance journal. The work explores the National Institute of Health (NIH) recommendation for prophylactic anticoagulant use for pregnant patients...
by Truveta Staff | May 19, 2023 | Technology
The Wall Street Journal recently published a story, If Your Toddler Isn’t Talking Yet, the Pandemic Might Be to Blame, based on a new pre-print published by Truveta Research on MedRxiv, which investigated speech delays in children under age 5 as an unexpected outcome...
